187 related articles for article (PubMed ID: 15955371)
21. Impact of incretin therapy on islet dysfunction: an underlying defect in the pathophysiology of type 2 diabetes.
McGill JB
Postgrad Med; 2009 Jan; 121(1):46-58. PubMed ID: 19179813
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
Evans AJ; Krentz AJ
Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
[No Abstract] [Full Text] [Related]
23. Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinediones.
Del Prato S; Marchetti P
Diabetes Technol Ther; 2004 Oct; 6(5):719-31. PubMed ID: 15628822
[TBL] [Abstract][Full Text] [Related]
24. [Drug treatment of type 2 diabetes].
Tielmans A; Laloi-Michelin M; Coupaye M; Virally M; Meas T; Guillausseau PJ
Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
[TBL] [Abstract][Full Text] [Related]
25. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
26. Current views on the mechanism of action of thiazolidinedione insulin sensitizers.
Goldstein BJ
Diabetes Technol Ther; 1999; 1(3):267-75. PubMed ID: 11475273
[TBL] [Abstract][Full Text] [Related]
27. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
28. [Glitazones and pancreatic function].
Girard J
Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S18-23. PubMed ID: 15959401
[TBL] [Abstract][Full Text] [Related]
29. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
Massi-Benedetti M; Orsini-Federici M
Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
[TBL] [Abstract][Full Text] [Related]
30. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
Efendic S; Alvarsson M; Brismar K; Wagner H
Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
[TBL] [Abstract][Full Text] [Related]
31. Improving glycaemic control with current therapies.
Birkeland KI
Diabet Med; 1998; 15 Suppl 4():S13-9. PubMed ID: 9868986
[TBL] [Abstract][Full Text] [Related]
32. Beta- and alpha-cell dysfunction in type 2 diabetes.
Del Prato S; Marchetti P
Horm Metab Res; 2004; 36(11-12):775-81. PubMed ID: 15655708
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of insulin secretion.
Scheen AJ
Ann Endocrinol (Paris); 2004 Feb; 65(1):29-36. PubMed ID: 15122089
[TBL] [Abstract][Full Text] [Related]
34. Oral anti diabetic polychemotherapy in type 2 diabetes mellitus.
Gin H; Rigalleau V
Diabetes Metab; 2002 Nov; 28(5):350-3. PubMed ID: 12461471
[TBL] [Abstract][Full Text] [Related]
35. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.
Standl E; Füchtenbusch M
Diabetologia; 2003 Mar; 46 Suppl 1():M30-6. PubMed ID: 12652356
[TBL] [Abstract][Full Text] [Related]
36. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
Lam NT; Kieffer TJ
Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
[TBL] [Abstract][Full Text] [Related]
37. The pathophysiological basis for intensive insulin replacement.
Rolla A
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S3-7. PubMed ID: 15306831
[TBL] [Abstract][Full Text] [Related]
38. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
Goodarzi MO; Bryer-Ash M
Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
[TBL] [Abstract][Full Text] [Related]
39. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
Tatoń J; Koliński P
Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
[No Abstract] [Full Text] [Related]
40. Potential new treatments for type 2 diabetes.
Bailey CJ
Trends Pharmacol Sci; 2000 Jul; 21(7):259-65. PubMed ID: 10871894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
